---
category: news
title: "Dyno Inks Up to $2B+ in Gene Therapy Partnerships with Novartis, Sarepta"
excerpt: "Dyno Therapeutics, a gene therapy developer emerging from stealth mode, could generate more than $2 billion through collaborations launched with Novartis and Sarepta Therapeutics to develop treatments based on a delivery platform developed in the lab of George Church,"
publishedDateTime: 2020-05-11T13:37:00Z
webUrl: "https://www.genengnews.com/news/dyno-inks-up-to-2b-in-gene-therapy-partnerships-with-novartis-sarepta/"
type: article
quality: 38
heat: -1
published: false

provider:
  name: GEN
  domain: genengnews.com

topics:
  - AI in Healthcare
  - AI

images:
  - url: "https://www.genengnews.com/wp-content/uploads/2020/05/Novartis_genetherapy_cell-processing-specialist-lab-hero-image.jpg"
    width: 1600
    height: 800
    title: "Dyno Inks Up to $2B+ in Gene Therapy Partnerships with Novartis, Sarepta"

related:
  - title: "Novartis, Sarepta partner with new George Church gene therapy startup"
    excerpt: "Dyno Therapeutics launched Monday with plans to use artificial intelligence to expand the use of gene therapy. The company was co-founded by George Church, the noted Harvard University geneticist, and others."
    publishedDateTime: 2020-05-11T11:05:00Z
    webUrl: "https://www.bizjournals.com/boston/news/2020/05/11/novartis-sarepta-partner-with-new-george-church.html"
    ampWebUrl: "https://www.bizjournals.com/boston/news/2020/05/11/novartis-sarepta-partner-with-new-george-church.amp.html"
    cdnAmpWebUrl: "https://www-bizjournals-com.cdn.ampproject.org/c/s/www.bizjournals.com/boston/news/2020/05/11/novartis-sarepta-partner-with-new-george-church.amp.html"
    type: article
    provider:
      name: The Business Journals
      domain: bizjournals.com
    quality: 59
    images:
      - url: "https://media.bizj.us/view/img/11660263/dyno-ceo-eric-kelsic*600xx2201-1467-0-367.jpg"
        width: 600
        height: 399
  - title: "Dyno spins out of Harvard's laboratories with an aim to make gene therapy better"
    excerpt: "The startup announced collaborations with Novartis and Sarepta, both leading gene therapy makers, that could be worth $2 billion in total."
    publishedDateTime: 2020-05-11T16:30:00Z
    webUrl: "https://www.biopharmadive.com/news/harvard-gene-therapy-dyno-sarepta-novartis/577675/"
    type: article
    provider:
      name: BioPharma Dive
      domain: biopharmadive.com
    quality: 49
    images:
      - url: "https://www.biopharmadive.com/user_media/cache/60/11/6011147973e6d6690c235b55cfd22dac.jpg"
        width: 770
        height: 364
  - title: "Dyno Therapeutics Emerges from Stealth to Transform Gene Therapy Using Artificial Intelligence"
    excerpt: "Dyno Therapeutics, Inc., a biotechnology company applying artificial intelligence (AI) to gene therapy, today announced the company’s launch from stealth mode with its proprietary platform, CapsidMap™."
    publishedDateTime: 2020-05-11T11:16:00Z
    webUrl: "https://www.businesswire.com/news/home/20200511005265/en/Dyno-Therapeutics-Emerges-Stealth-Transform-Gene-Therapy"
    type: article
    provider:
      name: Business Wire
      domain: businesswire.com
    quality: 42
    images:
      - url: "https://mms.businesswire.com/media/20200511005265/en/790645/23/Dyno-Logo-Final-050820.jpg"
        width: 1200
        height: 627
  - title: "Novartis, Sarepta tap Dyno to unearth new gene therapy vectors"
    excerpt: "Although gene therapy has opened a new realm of possibilities, its delivery vehicles have held it back. Dyno Therapeutics is on a mission to change that—and it’s coming out of stealth with artificial-intelligence-powered technology and partnerships with Novartis and Sarepta Therapeutics that could net it up to $2 billion."
    publishedDateTime: 2020-05-11T11:00:00Z
    webUrl: "https://www.fiercebiotech.com/biotech/novartis-sarepta-tap-dyno-to-unearth-new-gene-therapy-vectors"
    type: article
    provider:
      name: FierceBiotech
      domain: fiercebiotech.com
    quality: 39
    images:
      - url: "https://qtxasset.com/fiercebiotech/1588979831/dna-1903318_1280.jpg/dna-1903318_1280.jpg?t.2eZ5FSDr1S5ybezl5h3kF0HskfKFHY"
        width: 1280
        height: 720
  - title: "Dyno Therapeutics Announces Ocular Collaboration with Novartis to Develop Improved Gene Therapies with AAV Vectors based on AI Technology"
    excerpt: "Dyno Therapeutics Announces Ocular Collaboration with Novartis to Develop Improved Gene Therapies with AAV Vectors based on AI Technology"
    publishedDateTime: 2020-05-11T12:56:00Z
    webUrl: "https://www.businesswire.com/news/home/20200511005266/en/Dyno-Therapeutics-Announces-Ocular-Collaboration-Novartis-Develop"
    type: article
    provider:
      name: Business Wire
      domain: businesswire.com
    quality: 6
    images:
      - url: "https://mms.businesswire.com/media/20200511005266/en/790645/23/Dyno-Logo-Final-050820.jpg"
        width: 1200
        height: 627

secured: "nWyEBN0aA8Zri+zC/WlaYEjj3tPO7OrOhCtVHGCR9p8CxNl3mulXIXE2yNXVXA99fBzfPn3T4tNzwJDnI0slgSXheieUUdMxrIOS49hMNRTZZA5mpEFYkkR+LQTT+Jgc4xdhqj5Hjc9q2F778Wu9Y3hYk7RtarR65vohCWwZhru84UF1ndm0tChESWCuvFqmQHk8NKoHKHRRRX8OuvNabM5rGz2POZ6SUPIhY1HFuJFy0M00W/RzLE2AnfzJJvi+MLY9iuVpJuGRfpEFd0t53Z2wXT7PDn3vaf6M2Zu92e3LApyDf+KEbi6M3MQ4RN2k;BHyIA91lqpWwqqL6UaXX+g=="
---

